Skip to main content

Medications for Glaucoma/Intraocular Hypertension

A group of eye diseases characterised by an increase in intraocular pressure which causes pathological changes in the optic disk and typical defects in the field of vision.

Drugs used to treat Glaucoma/Intraocular Hypertension

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Combigan 10 1 review for Combigan to treat Glaucoma/Intraocular Hypertension
Rx C N X
Generic name:
brimonidine / timolol ophthalmic
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zioptan 4.3 5 reviews for Zioptan to treat Glaucoma/Intraocular Hypertension
Rx C N
Generic name:
tafluprost ophthalmic
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
brimonidine / timolol 10 2 reviews for brimonidine / timolol to treat Glaucoma/Intraocular Hypertension
Rx C N X
Generic name:
brimonidine / timolol ophthalmic
Brand name:
Combigan
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Vyzulta 7.6 6 reviews for Vyzulta to treat Glaucoma/Intraocular Hypertension
Rx N
Generic name:
latanoprostene bunod ophthalmic
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
latanoprostene bunod 8.0 7 reviews for latanoprostene bunod to treat Glaucoma/Intraocular Hypertension
Rx N
Generic name:
latanoprostene bunod ophthalmic
Brand name:
Vyzulta
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
tafluprost 4.2 6 reviews for tafluprost to treat Glaucoma/Intraocular Hypertension
Rx C N
Generic name:
tafluprost ophthalmic
Brand name:
Zioptan
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
omidenepag isopropyl Rate Add review
Rx N
Generic name:
omidenepag isopropyl ophthalmic
Brand name:
Omlonti
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Omlonti Rate Add review
Rx N
Generic name:
omidenepag isopropyl ophthalmic
Drug class:
ophthalmic glaucoma agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Learn more about Glaucoma/Intraocular Hypertension

Care guides

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.